The role of dopaminergic systems in γ‐hydroxybutyrate‐induced electrocorticogram hypersynchronization in the rat

The effects of dopaminergic agonists and antagonists on the duration of hypersynchronization induced in the electrocorticogram (ecog) by γ‐hydroxybutyrate (γ‐HB) were tested in rats. Apomorphine (0·2–8 mg kg−1), piribedil (2·5–10 mg kg−1) and haloperidol (0·5–1 mg kg−1) had no influence on the duration of the hypersynchrony. Amphetamine (1·5–6 mg kg−1) inhibited the hypersynchrony, while (3,4‐dihydroxyphenylamino)‐2‐imidazoline (DPI; 5, but not 1, mg kg−1) prolonged its duration. The lack of effect of the dopamine receptor agonists apomorphine and piribedil, and the dopamine receptor blocker haloperidol, on the γ‐HB‐induced hypersynchrony might indicate that the inhibition of the impulse flow in the nigrostriatal dopamine system by γ‐HB is not involved in the generation of the hypersynchrony. DPI is thought to be an agonist at a dopamine receptor not sensitive to apomorphine, and its facilitatory effect on γ‐HB‐hypersynchrony can be interpreted in terms of a possible involvement of another dopamine system in the ecog hypersynchrony induced by γ‐HB. The antagonism of γ‐HB by amphetamine is possibly due to an indirect stimulatory effect on noradrenergic receptors.

[1]  M. Godschalk,et al.  Slow wave sleep and a state resembling absence epilepsy induced in the rat by γ-hydroxybutyrate , 1977 .

[2]  M. C. Gerald,et al.  Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice , 1976, Neuropharmacology.

[3]  M. Godschalk,et al.  Antagonism of gamma-hydroxybutyrate-induced hypersynchronization in the ECoG of the rat by anti-petit mal drugs , 1976, Neuroscience Letters.

[4]  J. Gaillard,et al.  Brain dopamine receptors and sleep in the rat: effects of stimulation and blockade. , 1976, European journal of pharmacology.

[5]  J. Walters,et al.  Dopamine in substantia nigra and cortex after γ‐butyrolactone treatment , 1976 .

[6]  A R Cools,et al.  Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain. , 1976, European journal of pharmacology.

[7]  C. Pycock,et al.  Ergot alkaloids as dopamine agonists: comparison in two rodent models. , 1976, European journal of pharmacology.

[8]  B. Cox,et al.  Brain amines and spontaneous epileptic seizures in the Mongolian gerbil , 1976, Pharmacology Biochemistry and Behavior.

[9]  W. D. Winters,et al.  Neuropharmacological effects induced by butanol, 4-hydroxybutyrate, 4-mercaptobutyric acid thiolactone, tetrahydrofuran, pyrrolidine, 2-deoxy-d-glucose and related substances in the rat , 1976, Neuropharmacology.

[10]  A. Handforth,et al.  Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment , 1975 .

[11]  A. Cools,et al.  (3,4‐Dihydroxy‐phenylamino)‐2‐imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition , 1975, The Journal of pharmacy and pharmacology.

[12]  M. Trimble,et al.  Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio. , 1975, European journal of pharmacology.

[13]  R. Stull,et al.  Effects of dopamine receptor stimulation and blockade on Ro 4–1284‐induced enhancement of electroshock seizure , 1973, The Journal of pharmacy and pharmacology.

[14]  U. Ungerstedt,et al.  Evidence for a new type of dopamine receptor stimulating agent , 1971, The Journal of pharmacy and pharmacology.

[15]  R. Roth,et al.  Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. , 1970, The Journal of pharmacology and experimental therapeutics.

[16]  T. Hökfelt,et al.  Evidence for dopamine receptor stimulation by apomorphine , 1967, The Journal of pharmacy and pharmacology.

[17]  P. Spano,et al.  Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action. , 1966, Journal of neurochemistry.

[18]  S. Livingston,et al.  The use of benzedrine and dexedrine sulfate in the treatment of epilepsy. , 1948, The Journal of pediatrics.